Company Filing History:
Years Active: 2017
Title: Stephanie Mcardle: Innovator in Breast Cancer Screening
Introduction
Stephanie Mcardle is a notable inventor based in Nottingham, GB. She has made significant contributions to the field of breast cancer research, particularly through her innovative patent that focuses on screening methods for the disease. Her work aims to improve the prognosis and treatment options for breast cancer patients.
Latest Patents
Stephanie holds a patent for a breast cancer assay. This application describes a method of screening for breast cancer by testing for the amount of HAGE (Helicase antigen) in a sample of breast tissue. The patent also provides methods for the prognosis of breast cancer tumor samples. Notably, HAGE+ ER− (estrogen receptor-) cancers are indicated as being amenable to chemotherapy. Additionally, the patent outlines methods for treating breast cancers using HAGE-specific CTA antigens or HAGE-specific antibodies.
Career Highlights
Stephanie is affiliated with Nottingham Trent University, where she continues her research and development in cancer screening technologies. Her work has the potential to significantly impact the way breast cancer is diagnosed and treated, providing new hope for patients.
Collaborations
Stephanie collaborates with colleagues such as Adam Linley and Chungui Lu, who contribute to her research efforts and help advance the field of breast cancer diagnostics.
Conclusion
Stephanie Mcardle's innovative work in breast cancer screening exemplifies the importance of research in improving patient outcomes. Her contributions through her patent and collaborations highlight her commitment to advancing medical science.